COMMUNIQUÉS West-GlobeNewswire

Terveystalo Group Interim Report 1 January - 30 September 2018
14/11/2018
Terveystalo Plc. Interim report 14 November 2018 at 9:00 a.m. EET Strong earnings trend continued July-September 2018 in brief Revenue increased by 3.2 percent year-on-year to EUR 160.3 million (155.4) Adjusted* EBITDA [...]
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2018
14/11/2018
Message from the CEO The third quarter was dominated by extensive preparatory work relating to the planned phase III study, called “The Connection Study”. In addition to chosing the CRO (Premier Research) we have [...]
Rule 2.9 Announcement
14/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 14 November 2018 [...]
Saniona publishes its interim report for the third quarter 2018
14/11/2018
PRESS RELEASE November 14, 2018 Financial highlights Jan – Sep 2018 (Jan - Sep 2017) Net revenues were SEK 52.7 M (16.1 M) EBIT was SEK -19.9 M (-40.6 M) Net profit/loss was SEK -17.7 M (-34.4) Earnings per share were [...]
Basilea presents preclinical data on its anticancer drug candidate BAL101553 at EORTC-NCI-AACR symposium
14/11/2018
Late-breaking abstracts on increased cure rates and synergistic effects of combinations with eribulin and gemcitabine in solid tumor models Enhanced survival in a brain tumor model after single agent treatment Basel, [...]
Tabula Rasa HealthCare to Participate in Upcoming Investor Conference
14/11/2018
MOORESTOWN, N.J., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced that Chief Financial [...]
CareDx Announces Pricing of Public Offering of Common Stock
14/11/2018
BRISBANE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Innovate Biopharmaceuticals Reports Third Quarter 2018 Earnings and Key Corporate Highlights
13/11/2018
Poster presentation at the American Association of Study of Liver Diseases showing promising pre-clinical data of larazotide acetate in NASH reducing intestinal permeability. Innovate plans to initiate a Phase 2 [...]
Loop Industries Closes $2.45M Private Placement
13/11/2018
MONTREAL, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq: LOOP ) ("Loop" or the "Company"), a leading technology innovator in sustainable plastic, today announced the closing of a private placement [...]
Helix BioPharma Corp. Provides Strategic Update on L-DOS47 Clinical Program
13/11/2018
RICHMOND HILL, Ontario, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, provides a strategic [...]
Loop Industries Announces Change of CFO
13/11/2018
MONTREAL, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Loop Industries (Nasdaq:LOOP) (“Loop” or “Company”), a leading technology innovator in sustainable plastic resin and polyester fiber, today announced that CFO Frank Zitella [...]
Delcath Announces Third Quarter Fiscal 2018 Financial Results
13/11/2018
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces financial results for the [...]
Altimmune Announces Third Quarter 2018 Financial Results and Provides Corporate Update
13/11/2018
GAITHERSBURG, Md., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three and nine months ended September 30, 2018. [...]
Zomedica Pharmaceuticals Corp. Announces Third Quarter 2018 Financial Results
13/11/2018
ANN ARBOR, Mich., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today reported [...]
National Brain Tumor Society Supported Work Features in 19 Presentations at 2018 Society for Neuro-Oncology Annual Meeting
13/11/2018
Boston, MA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced that its funded research, programs, [...]
Molecular Templates, Inc. Reports Third Quarter 2018 Financial Results and Provides Corporate Update
13/11/2018
AUSTIN, Texas, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular” or “Molecular Templates”), a clinical-stage oncology company focused on the discovery and development of the company’ [...]
Adverum to Present at 30th Annual Piper Jaffray Healthcare Conference
13/11/2018
MENLO PARK, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today announced [...]
Alcon files initial Form 20-F registration statement with SEC for proposed spinoff; plans investor days in New York and London
13/11/2018
Basel, November 13, 2018 - Novartis today announced that Alcon has filed an initial Form 20-F registration statement with the US Securities and Exchange Commission (SEC) in relation to the previously-announced intention [...]
Mustang Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
13/11/2018
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell (“ [...]

Pages